Homeodomain-only protein (HOPX)

Homeodomain-only protein (HOPX) is a unique member of the homeodomain protein family that functions as a transcriptional regulator but, unlike other homeobox proteins, lacks DNA-binding ability due to missing conserved residues. HOPX acts primarily through protein–protein interactions with other transcriptional regulators, such as serum response factor (SRF) and histone deacetylases, to modulate gene expression and chromatin structure. It plays essential roles in heart development, cardiomyocyte maturation, differentiation of muscle, epithelial, and neuronal cells, and the maintenance of tissue homeostasis. In cancer, HOPX acts as a tumor suppressor and is frequently downregulated by promoter methylation, especially in solid tumors including lung, head and neck, colon, and others. Restoration of HOPX expression suppresses proliferation and metastasis, positioning it as a promising biomarker and a potential therapeutic target for epigenetic interventions. Key points: HOPX is not a classical DNA-binding transcription factor but mediates effects through interacting proteins. Acts as a tumor suppressor in multiple cancers; loss or silencing of HOPX correlates with worse outcomes. No direct drug targeting is established, but demethylating agents can potentially reactivate silenced HOPX in cancer cells. Methylation status of HOPX is used as a tumor biomarker in some contexts.

Other names

HODHOPLAGYNECC1OB1SMAP31TOTOCameoLung cancer-associated Y proteinNot expressed in choriocarcinoma protein 1Odd homeobox protein 1homeobox only domain

Transcriptional co-regulation via interaction with other transcription factors (e.g., SRF, GATA4). Epigenetic silencing via promoter methylation, which can be reversed by demethylating agents to restore HOPX expression.